Rakuten Securities’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.4K Sell
59
-103
-64% -$5.91K ﹤0.01% 598
2026
Q1
$9.82K Sell
162
-750
-82% -$43.7K ﹤0.01% 428
2025
Q4
$49.2K Sell
912
-1,058
-54% -$50.9K 0.02% 246
2025
Q3
$88.8K Buy
1,970
+1,354
+220% +$63.2K 0.03% 198
2025
Q2
$28.5K Buy
616
+70
+13% +$3.44K 0.01% 280
2025
Q1
$33.3K Sell
546
-620
-53% -$36.1K 0.02% 253
2024
Q4
$65.9K Buy
1,166
+481
+70% +$26.9K 0.03% 186
2024
Q3
$35.4K Sell
685
-1,339
-66% -$62.8K 0.02% 211
2024
Q2
$84.1K Sell
2,024
-46
-2% -$2.06K 0.04% 137
2024
Q1
$112K Buy
2,070
+1,213
+142% +$61.8K 0.05% 125
2023
Q4
$44K Buy
+857
New +$45K 0.03% 167

Other funds holding BMY

Rakuten Securities's BMY Position: Q2 2026 in Review

Rakuten Securities reduced its Bristol-Myers Squibb (BMY) stake by 64% in Q2 2026, selling an estimated $5.91K and leaving 59 shares worth $3.4K. The position accounts for ﹤0.01% of the portfolio, ranked #598.

Rakuten Securities first reported a position in BMY in Q4 2023 and has held it in 11 quarters since. The position peaked at $112K in Q1 2024. 2,508 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Rakuten Securities held 59 shares of Bristol-Myers Squibb worth $3.4K as of Q2 2026.
  • Rakuten Securities sold 103 Bristol-Myers Squibb shares in Q2 2026, an estimated $5.91K.
  • Bristol-Myers Squibb made up ﹤0.01% of Rakuten Securities's portfolio in Q2 2026, its #598 holding.
  • Rakuten Securities first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 11 quarters since.
  • Rakuten Securities's Bristol-Myers Squibb position peaked at $112K in Q1 2024.
  • 2,508 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Rakuten Securities's 13F filing for Q2 2026, filed 12 Aug 2026.